Report an error

Spotted something inaccurate in “Nirsevimab Safety Monitoring Finds Low Adverse Event Rates in 23,143 Infants”? Tell us what’s wrong and we’ll check it against the original source.

Website

Send report Cancel

This form is for factual corrections. We read every report but cannot reply individually.